Additional Information

Description

Micc-B12 - Olympia Injection 25/50/50/330 mcg x 10 mL is a compounded formulation intended for the supplementation of vitamin B12. It is used in the treatment of vitamin B12 deficiency, which may be caused by dietary insufficiency, malabsorption, or certain medical conditions. As a compounded product, the safety and efficacy of this formulation have not been established through FDA evaluation, and it may vary depending on compounding practices.

The injection is typically administered intramuscularly as directed by a healthcare provider. The dosage and frequency of administration depend on the specific needs of the patient and the severity of the vitamin B12 deficiency. Monitoring for adverse effects is essential during the course of treatment to ensure that the patient responds appropriately to the therapy.

The potential interactions of Micc-B12 - Olympia Injection are expected to be similar to those of FDA-approved cyanocobalamin products. Common side effects may include injection site reactions and dizziness. It should be refrigerated at 2°C to 8°C (36°F to 46°F), protected from light, and must not be frozen to prevent degradation of the active ingredient.